CT-95 in Advanced Cancers Associated With Mesothelin Expression

Who May Qualify: - ECOG 0 or 1 - Subjects with evaluable disease per RECIST 1.1 or mRECIST - Subjects with your organs (liver, kidneys, etc.) are working well enough based on blood tests. - Subjects with advanced cancers associated with mesothelin expression Who Should NOT Join This Trial: - Uncontrolled significant active infection or any medical or other condition that in opinion of the investigator would preclude the subject's participation in the study. - Prior treatment with MSLN-targeted CD3 or chimeric antigen receptor T cell (CAR-T) therapy - Concurrent participation in another investigational clinical trial. - Evidence of leptomeningeal disease Always talk to your doctor about whether this trial is right for you.